| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| STAT3 Transcription Factor | 37 | 2022 | 1121 | 4.470 |
Why?
|
| Dendritic Cells | 18 | 2022 | 1085 | 3.870 |
Why?
|
| Receptors, Erythropoietin | 23 | 2011 | 70 | 1.970 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 8 | 2014 | 749 | 1.570 |
Why?
|
| Hematopoietic Stem Cells | 10 | 2018 | 1242 | 1.420 |
Why?
|
| Interleukin-6 | 13 | 2022 | 1038 | 1.330 |
Why?
|
| Neutrophils | 8 | 2022 | 835 | 1.320 |
Why?
|
| Signal Transduction | 40 | 2018 | 11965 | 1.210 |
Why?
|
| Cell Differentiation | 29 | 2020 | 4078 | 1.150 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 3 | 2016 | 17 | 1.130 |
Why?
|
| Myelopoiesis | 3 | 2014 | 31 | 1.100 |
Why?
|
| Interleukin-10 | 8 | 2022 | 478 | 1.060 |
Why?
|
| Colitis | 3 | 2023 | 340 | 0.980 |
Why?
|
| Immunity, Innate | 5 | 2018 | 677 | 0.970 |
Why?
|
| Interferon Type I | 3 | 2022 | 250 | 0.970 |
Why?
|
| STAT5 Transcription Factor | 6 | 2012 | 214 | 0.930 |
Why?
|
| Mice | 75 | 2024 | 34495 | 0.920 |
Why?
|
| Integrin alpha Chains | 2 | 2020 | 28 | 0.910 |
Why?
|
| Peyer's Patches | 2 | 2014 | 30 | 0.900 |
Why?
|
| Macrophages | 8 | 2022 | 1304 | 0.890 |
Why?
|
| Granulocytes | 3 | 2014 | 224 | 0.890 |
Why?
|
| Animals | 93 | 2024 | 59536 | 0.860 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2022 | 33 | 0.850 |
Why?
|
| Trans-Activators | 12 | 2009 | 1555 | 0.820 |
Why?
|
| Chemokine CXCL2 | 2 | 2012 | 35 | 0.810 |
Why?
|
| Erythropoietin | 13 | 2011 | 205 | 0.790 |
Why?
|
| Interferon Regulatory Factors | 2 | 2012 | 76 | 0.750 |
Why?
|
| Hematopoiesis | 4 | 2018 | 560 | 0.750 |
Why?
|
| Gene Expression Regulation | 18 | 2022 | 4053 | 0.740 |
Why?
|
| Microbiota | 3 | 2023 | 547 | 0.740 |
Why?
|
| Sarcoma, Experimental | 1 | 2020 | 68 | 0.730 |
Why?
|
| Melanoma, Experimental | 3 | 2021 | 368 | 0.680 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 5 | 2012 | 408 | 0.670 |
Why?
|
| Mice, Knockout | 23 | 2021 | 5710 | 0.650 |
Why?
|
| STAT Transcription Factors | 3 | 2019 | 79 | 0.640 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2018 | 93 | 0.640 |
Why?
|
| Antigens, CD | 2 | 2020 | 1385 | 0.630 |
Why?
|
| Blood Cells | 1 | 2018 | 127 | 0.620 |
Why?
|
| Immune System Diseases | 2 | 2016 | 65 | 0.610 |
Why?
|
| Cytokines | 11 | 2022 | 2809 | 0.600 |
Why?
|
| Milk Proteins | 3 | 2003 | 116 | 0.590 |
Why?
|
| STAT1 Transcription Factor | 2 | 2021 | 156 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 21 | 2021 | 6942 | 0.560 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 31 | 0.540 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 68 | 0.530 |
Why?
|
| Bone Marrow | 4 | 2016 | 2358 | 0.530 |
Why?
|
| Zinc Fingers | 1 | 2016 | 205 | 0.510 |
Why?
|
| Bone Marrow Cells | 5 | 2016 | 943 | 0.510 |
Why?
|
| Bone Marrow Diseases | 1 | 2016 | 177 | 0.500 |
Why?
|
| Vaccines | 1 | 2020 | 389 | 0.500 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 280 | 0.500 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 5 | 2013 | 60 | 0.500 |
Why?
|
| Immunity, Cellular | 1 | 2016 | 419 | 0.490 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 214 | 0.490 |
Why?
|
| Cell Lineage | 8 | 2019 | 668 | 0.490 |
Why?
|
| Adoptive Transfer | 4 | 2019 | 446 | 0.480 |
Why?
|
| RANK Ligand | 1 | 2014 | 119 | 0.480 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2019 | 582 | 0.470 |
Why?
|
| Tumor Microenvironment | 6 | 2022 | 2864 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 479 | 0.470 |
Why?
|
| Sequence Deletion | 3 | 2016 | 875 | 0.470 |
Why?
|
| Inflammation | 10 | 2022 | 2522 | 0.470 |
Why?
|
| NF-kappa B | 7 | 2020 | 1549 | 0.460 |
Why?
|
| DNA-Binding Proteins | 10 | 2014 | 4821 | 0.460 |
Why?
|
| Interleukin-17 | 8 | 2021 | 250 | 0.460 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 203 | 0.450 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2023 | 1249 | 0.450 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2012 | 246 | 0.450 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 6 | 2009 | 212 | 0.440 |
Why?
|
| Erythropoiesis | 3 | 2017 | 74 | 0.440 |
Why?
|
| Osteosarcoma | 1 | 2020 | 929 | 0.440 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2010 | 157 | 0.430 |
Why?
|
| Neoplasms | 7 | 2023 | 15193 | 0.410 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 314 | 0.410 |
Why?
|
| Interferon-alpha | 2 | 2017 | 889 | 0.410 |
Why?
|
| Autoimmunity | 3 | 2019 | 263 | 0.400 |
Why?
|
| Erythroid Precursor Cells | 3 | 2017 | 61 | 0.390 |
Why?
|
| Leukopoiesis | 1 | 2010 | 7 | 0.380 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2020 | 1586 | 0.380 |
Why?
|
| Immunotherapy | 6 | 2023 | 3341 | 0.370 |
Why?
|
| Fibroblasts | 3 | 2014 | 1682 | 0.360 |
Why?
|
| Melanoma | 5 | 2023 | 5317 | 0.350 |
Why?
|
| Lung Neoplasms | 6 | 2024 | 11538 | 0.340 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 35 | 0.340 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2012 | 1498 | 0.330 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2021 | 907 | 0.330 |
Why?
|
| Neutrophil Activation | 1 | 2008 | 34 | 0.320 |
Why?
|
| Endothelial Cells | 1 | 2014 | 1048 | 0.320 |
Why?
|
| Fecal Microbiota Transplantation | 3 | 2023 | 149 | 0.310 |
Why?
|
| Growth Inhibitors | 1 | 2008 | 149 | 0.310 |
Why?
|
| Interleukins | 4 | 2020 | 325 | 0.310 |
Why?
|
| Tyrosine | 4 | 2022 | 498 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 9 | 2014 | 3101 | 0.290 |
Why?
|
| Interferon-gamma | 3 | 2019 | 1144 | 0.280 |
Why?
|
| Chemotaxis | 1 | 2006 | 138 | 0.280 |
Why?
|
| RNA, Messenger | 7 | 2016 | 6150 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2009 | 2488 | 0.270 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 2 | 2017 | 56 | 0.270 |
Why?
|
| Cell Line | 17 | 2017 | 5114 | 0.260 |
Why?
|
| Macrophage-1 Antigen | 2 | 2002 | 51 | 0.260 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2022 | 1331 | 0.250 |
Why?
|
| Immunologic Memory | 2 | 2020 | 374 | 0.240 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 300 | 0.240 |
Why?
|
| MicroRNAs | 2 | 2017 | 2947 | 0.230 |
Why?
|
| Sulfones | 1 | 2024 | 143 | 0.230 |
Why?
|
| T-Lymphocytes | 5 | 2023 | 3869 | 0.220 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 4 | 2008 | 35 | 0.220 |
Why?
|
| Poly I-C | 1 | 2022 | 29 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2020 | 2359 | 0.220 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2021 | 1048 | 0.210 |
Why?
|
| Transcriptional Activation | 5 | 2014 | 1070 | 0.210 |
Why?
|
| Killer Cells, Natural | 3 | 2017 | 904 | 0.210 |
Why?
|
| Humans | 50 | 2024 | 261506 | 0.210 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 673 | 0.200 |
Why?
|
| Cells, Cultured | 10 | 2020 | 5637 | 0.200 |
Why?
|
| Pyridones | 1 | 2024 | 348 | 0.200 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2019 | 1033 | 0.200 |
Why?
|
| Mutation | 14 | 2022 | 15179 | 0.200 |
Why?
|
| Dietary Fiber | 1 | 2021 | 123 | 0.200 |
Why?
|
| Gene Expression | 5 | 2016 | 3570 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1491 | 0.190 |
Why?
|
| Transcription Factor 4 | 2 | 2012 | 36 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 1555 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2018 | 3639 | 0.190 |
Why?
|
| Cross-Priming | 1 | 2020 | 39 | 0.180 |
Why?
|
| Dysbiosis | 1 | 2021 | 134 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 591 | 0.180 |
Why?
|
| Interferons | 1 | 2021 | 291 | 0.180 |
Why?
|
| Membrane Proteins | 1 | 2010 | 2819 | 0.180 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 4143 | 0.180 |
Why?
|
| Cytoplasm | 2 | 1999 | 652 | 0.180 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 4 | 2006 | 24 | 0.180 |
Why?
|
| Transcription, Genetic | 5 | 2019 | 3154 | 0.180 |
Why?
|
| Glioblastoma | 2 | 2022 | 1797 | 0.180 |
Why?
|
| Immunophenotyping | 2 | 2016 | 1681 | 0.180 |
Why?
|
| Receptors, CXCR5 | 1 | 2019 | 27 | 0.170 |
Why?
|
| Polycythemia | 1 | 1999 | 49 | 0.170 |
Why?
|
| CD28 Antigens | 1 | 2020 | 202 | 0.170 |
Why?
|
| Antigen Presentation | 1 | 2020 | 272 | 0.170 |
Why?
|
| Immunomodulation | 1 | 2020 | 242 | 0.170 |
Why?
|
| Integrins | 1 | 2000 | 262 | 0.170 |
Why?
|
| Mycoses | 1 | 2022 | 386 | 0.170 |
Why?
|
| Probiotics | 1 | 2021 | 228 | 0.170 |
Why?
|
| I-kappa B Proteins | 1 | 2019 | 170 | 0.170 |
Why?
|
| Stem Cells | 2 | 2019 | 1213 | 0.160 |
Why?
|
| Transfection | 9 | 2006 | 2944 | 0.160 |
Why?
|
| In Vitro Techniques | 2 | 2020 | 1618 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 4 | 2020 | 5395 | 0.160 |
Why?
|
| Protein Binding | 8 | 2023 | 3438 | 0.160 |
Why?
|
| Receptors, Cell Surface | 2 | 2012 | 862 | 0.160 |
Why?
|
| Histones | 3 | 2014 | 1466 | 0.160 |
Why?
|
| Cell Proliferation | 6 | 2020 | 7226 | 0.160 |
Why?
|
| Cysteine Endopeptidases | 1 | 2019 | 251 | 0.160 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2017 | 15 | 0.160 |
Why?
|
| Fibrinogen | 1 | 2019 | 205 | 0.160 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2017 | 19 | 0.160 |
Why?
|
| Arginase | 2 | 2010 | 48 | 0.150 |
Why?
|
| Base Sequence | 7 | 2014 | 4917 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2003 | 611 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2023 | 5178 | 0.150 |
Why?
|
| Homeostasis | 3 | 2018 | 950 | 0.150 |
Why?
|
| CTLA-4 Antigen | 1 | 2021 | 657 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2019 | 8873 | 0.150 |
Why?
|
| Mast Cells | 2 | 2009 | 223 | 0.150 |
Why?
|
| Enzyme Activation | 4 | 2014 | 1764 | 0.140 |
Why?
|
| Cell Line, Tumor | 10 | 2021 | 14551 | 0.140 |
Why?
|
| Estrogens | 1 | 2020 | 751 | 0.140 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 7 | 0.140 |
Why?
|
| Janus Kinases | 2 | 2014 | 174 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2018 | 269 | 0.140 |
Why?
|
| Side-Population Cells | 1 | 2016 | 18 | 0.140 |
Why?
|
| Leukemia, Erythroblastic, Acute | 4 | 2009 | 118 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 518 | 0.140 |
Why?
|
| Molecular Sequence Data | 12 | 2014 | 6089 | 0.140 |
Why?
|
| Models, Biological | 4 | 2018 | 3254 | 0.140 |
Why?
|
| Stomach | 1 | 2019 | 387 | 0.140 |
Why?
|
| Sex Characteristics | 1 | 2018 | 417 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 612 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 6550 | 0.140 |
Why?
|
| Receptors, Cytokine | 2 | 1996 | 176 | 0.140 |
Why?
|
| Immunoblotting | 4 | 2013 | 886 | 0.140 |
Why?
|
| Protein Conformation | 5 | 2011 | 1258 | 0.130 |
Why?
|
| Valproic Acid | 1 | 2017 | 263 | 0.130 |
Why?
|
| Phosphorylation | 10 | 2017 | 4804 | 0.130 |
Why?
|
| Genes, Reporter | 2 | 2016 | 798 | 0.130 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 424 | 0.130 |
Why?
|
| Carcinogenesis | 2 | 2019 | 1026 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 149 | 0.130 |
Why?
|
| Ubiquitination | 2 | 2014 | 575 | 0.130 |
Why?
|
| Gastric Mucosa | 1 | 2019 | 613 | 0.130 |
Why?
|
| Transcription Factors | 6 | 2012 | 5270 | 0.130 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 36 | 0.130 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2014 | 7 | 0.130 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2014 | 37 | 0.130 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 86 | 0.130 |
Why?
|
| Amino Acid Sequence | 12 | 2008 | 4233 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 365 | 0.130 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2015 | 90 | 0.120 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2011 | 801 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2019 | 1489 | 0.120 |
Why?
|
| Receptors, Estrogen | 2 | 2019 | 2086 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 7222 | 0.120 |
Why?
|
| Listeria monocytogenes | 2 | 2014 | 52 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 208 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2014 | 558 | 0.120 |
Why?
|
| Cell Survival | 6 | 2017 | 3045 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2017 | 492 | 0.120 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2014 | 73 | 0.120 |
Why?
|
| Lymphocyte Activation | 6 | 2019 | 1688 | 0.120 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 96 | 0.120 |
Why?
|
| Germinal Center | 2 | 2019 | 161 | 0.120 |
Why?
|
| Recombinant Proteins | 6 | 2011 | 2927 | 0.120 |
Why?
|
| Immunoprecipitation | 3 | 2010 | 591 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1506 | 0.110 |
Why?
|
| Bacterial Infections | 2 | 2008 | 479 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 223 | 0.110 |
Why?
|
| Liver | 2 | 2000 | 2961 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1443 | 0.110 |
Why?
|
| CD11c Antigen | 1 | 2012 | 55 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2016 | 1163 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2014 | 250 | 0.110 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2010 | 191 | 0.110 |
Why?
|
| CD11b Antigen | 1 | 2012 | 66 | 0.110 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2012 | 56 | 0.110 |
Why?
|
| Female | 20 | 2024 | 141928 | 0.110 |
Why?
|
| Leukocyte Common Antigens | 1 | 2012 | 188 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 1823 | 0.110 |
Why?
|
| Point Mutation | 2 | 1997 | 769 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2016 | 619 | 0.110 |
Why?
|
| Cell Division | 4 | 2003 | 2489 | 0.110 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 23 | 0.100 |
Why?
|
| Binding Sites | 3 | 2014 | 2171 | 0.100 |
Why?
|
| RNA Polymerase II | 1 | 2012 | 182 | 0.100 |
Why?
|
| Anemia | 1 | 2017 | 689 | 0.100 |
Why?
|
| Cell Communication | 1 | 2014 | 509 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 343 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2014 | 461 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 2045 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2018 | 1818 | 0.100 |
Why?
|
| DNA Repair | 1 | 2019 | 1872 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 3251 | 0.100 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2007 | 93 | 0.100 |
Why?
|
| Cancer Vaccines | 1 | 2016 | 697 | 0.100 |
Why?
|
| Glioma | 1 | 2022 | 1963 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 507 | 0.090 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 487 | 0.090 |
Why?
|
| Receptors, Interleukin-8 | 1 | 2010 | 6 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 987 | 0.090 |
Why?
|
| Mycobacterium | 1 | 2010 | 56 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2023 | 2074 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 62 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2014 | 398 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 287 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 132 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2011 | 162 | 0.090 |
Why?
|
| Repressor Proteins | 3 | 2009 | 1664 | 0.090 |
Why?
|
| Erythroblasts | 1 | 2009 | 24 | 0.090 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2007 | 365 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 314 | 0.090 |
Why?
|
| B-Lymphocytes | 5 | 2019 | 1294 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 15694 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2012 | 810 | 0.090 |
Why?
|
| Receptors, CCR6 | 1 | 2008 | 22 | 0.090 |
Why?
|
| Feces | 2 | 2023 | 770 | 0.080 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2008 | 41 | 0.080 |
Why?
|
| Immune System | 1 | 2010 | 279 | 0.080 |
Why?
|
| Flow Cytometry | 3 | 2010 | 3033 | 0.080 |
Why?
|
| Quality of Life | 1 | 2022 | 4532 | 0.080 |
Why?
|
| Cell Adhesion | 2 | 2002 | 1008 | 0.080 |
Why?
|
| Receptors, IgE | 1 | 2008 | 39 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 2009 | 284 | 0.080 |
Why?
|
| Conserved Sequence | 2 | 2007 | 469 | 0.080 |
Why?
|
| Male | 11 | 2023 | 123000 | 0.080 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 52 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 612 | 0.080 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1999 | 261 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 5 | 1996 | 308 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 2009 | 461 | 0.080 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2007 | 7 | 0.080 |
Why?
|
| Genotype | 1 | 2016 | 4109 | 0.080 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2012 | 992 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2007 | 96 | 0.080 |
Why?
|
| Bone Neoplasms | 1 | 2020 | 2576 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2007 | 84 | 0.070 |
Why?
|
| Arginine | 1 | 2010 | 500 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 1390 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2291 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 423 | 0.070 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2006 | 62 | 0.070 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2006 | 96 | 0.070 |
Why?
|
| Receptors, Interleukin | 1 | 2006 | 97 | 0.070 |
Why?
|
| Leukemia | 2 | 2014 | 1635 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 260 | 0.070 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2012 | 1283 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2016 | 3536 | 0.070 |
Why?
|
| Kinetics | 5 | 1997 | 2049 | 0.070 |
Why?
|
| Toxoplasma | 1 | 2005 | 14 | 0.070 |
Why?
|
| Lymphoma | 1 | 2014 | 1467 | 0.070 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2005 | 66 | 0.060 |
Why?
|
| Asthma | 1 | 2013 | 871 | 0.060 |
Why?
|
| Alphavirus | 1 | 2005 | 20 | 0.060 |
Why?
|
| Carrier Proteins | 3 | 2003 | 2022 | 0.060 |
Why?
|
| Cytoplasmic Granules | 1 | 2005 | 89 | 0.060 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 5159 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2010 | 2084 | 0.060 |
Why?
|
| Cell Membrane | 4 | 2001 | 850 | 0.060 |
Why?
|
| Biomarkers | 1 | 2016 | 5047 | 0.060 |
Why?
|
| COS Cells | 2 | 2002 | 377 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2005 | 177 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2006 | 519 | 0.060 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2008 | 96 | 0.060 |
Why?
|
| Leukocyte Elastase | 1 | 2024 | 70 | 0.060 |
Why?
|
| HCT116 Cells | 2 | 2015 | 348 | 0.060 |
Why?
|
| Protein Biosynthesis | 2 | 2005 | 889 | 0.060 |
Why?
|
| STAT6 Transcription Factor | 3 | 2010 | 67 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2012 | 1533 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2005 | 253 | 0.060 |
Why?
|
| Interleukin-15 | 2 | 2015 | 185 | 0.060 |
Why?
|
| Neutropenia | 1 | 2008 | 968 | 0.060 |
Why?
|
| Germ-Free Life | 1 | 2023 | 69 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 4367 | 0.060 |
Why?
|
| Macromolecular Substances | 2 | 1994 | 293 | 0.060 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2023 | 101 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 1487 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2003 | 107 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2015 | 2314 | 0.050 |
Why?
|
| Molecular Chaperones | 2 | 1995 | 264 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 3578 | 0.050 |
Why?
|
| Heat-Shock Proteins | 2 | 1995 | 311 | 0.050 |
Why?
|
| Cysteine | 2 | 1994 | 214 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2000 | 331 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 52 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2019 | 7548 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2007 | 846 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 467 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 4849 | 0.050 |
Why?
|
| DNA Primers | 2 | 2002 | 1399 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 490 | 0.050 |
Why?
|
| Prognosis | 2 | 2016 | 21713 | 0.050 |
Why?
|
| Pyridines | 2 | 2019 | 1244 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 1217 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 1 | 2000 | 249 | 0.050 |
Why?
|
| CD18 Antigens | 1 | 2000 | 83 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2023 | 37905 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2000 | 221 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 1999 | 38 | 0.050 |
Why?
|
| Receptors, Somatotropin | 1 | 1999 | 17 | 0.050 |
Why?
|
| G1 Phase | 1 | 2000 | 285 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2000 | 287 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1538 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2019 | 53 | 0.040 |
Why?
|
| Biopolymers | 1 | 1999 | 38 | 0.040 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2019 | 38 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2019 | 60 | 0.040 |
Why?
|
| Chemokine CCL20 | 1 | 2019 | 39 | 0.040 |
Why?
|
| Dimerization | 1 | 1999 | 304 | 0.040 |
Why?
|
| Proteins | 2 | 2008 | 1963 | 0.040 |
Why?
|
| Genes, ras | 1 | 2022 | 667 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 2 | 2019 | 1130 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2022 | 649 | 0.040 |
Why?
|
| Janus Kinase 2 | 2 | 2000 | 679 | 0.040 |
Why?
|
| Immunity | 1 | 2020 | 342 | 0.040 |
Why?
|
| Platelet Count | 1 | 1999 | 490 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 193 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5319 | 0.040 |
Why?
|
| Adenocarcinoma | 3 | 2019 | 7789 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 1999 | 684 | 0.040 |
Why?
|
| Protein Stability | 1 | 2019 | 370 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2007 | 37 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2019 | 626 | 0.040 |
Why?
|
| Chemokines | 1 | 2019 | 314 | 0.040 |
Why?
|
| Leupeptins | 2 | 2014 | 68 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 334 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2018 | 260 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 534 | 0.040 |
Why?
|
| Endocytosis | 1 | 1998 | 225 | 0.040 |
Why?
|
| Neuroglia | 1 | 2019 | 223 | 0.040 |
Why?
|
| Fetus | 1 | 2000 | 601 | 0.040 |
Why?
|
| Protein Folding | 2 | 1995 | 281 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2020 | 1763 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 634 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 2 | 1995 | 218 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 15862 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2022 | 834 | 0.040 |
Why?
|
| Forecasting | 1 | 1999 | 694 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 733 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2008 | 3203 | 0.040 |
Why?
|
| Heterozygote | 1 | 1999 | 1020 | 0.040 |
Why?
|
| Disease Progression | 2 | 2019 | 6682 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 709 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 508 | 0.030 |
Why?
|
| Viral Envelope Proteins | 1 | 1997 | 207 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 1213 | 0.030 |
Why?
|
| Pedigree | 1 | 1999 | 1890 | 0.030 |
Why?
|
| Azoxymethane | 1 | 2015 | 43 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2015 | 72 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2000 | 1756 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 158 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1995 | 161 | 0.030 |
Why?
|
| Luciferases | 2 | 2006 | 445 | 0.030 |
Why?
|
| PPAR delta | 1 | 2015 | 55 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1994 | 96 | 0.030 |
Why?
|
| Job Syndrome | 1 | 2014 | 19 | 0.030 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2014 | 38 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 264 | 0.030 |
Why?
|
| Listeriosis | 1 | 2014 | 35 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2012 | 2450 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 125 | 0.030 |
Why?
|
| Friend murine leukemia virus | 2 | 2009 | 5 | 0.030 |
Why?
|
| Lymphoma, Follicular | 1 | 2019 | 587 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2014 | 102 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 1165 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 3343 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 1993 | 78 | 0.030 |
Why?
|
| Phenotype | 2 | 2018 | 6295 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2018 | 1442 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 184 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 973 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2013 | 185 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 174 | 0.030 |
Why?
|
| Introns | 1 | 1994 | 432 | 0.030 |
Why?
|
| Epitopes | 1 | 1995 | 685 | 0.030 |
Why?
|
| Clone Cells | 1 | 1994 | 555 | 0.030 |
Why?
|
| Multigene Family | 1 | 1994 | 425 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1987 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2014 | 144 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1994 | 869 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 1146 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 1489 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 1992 | 26 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 1271 | 0.030 |
Why?
|
| HN Protein | 1 | 1992 | 9 | 0.030 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2012 | 17 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2014 | 251 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 2006 | 5061 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 2330 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2001 | 997 | 0.030 |
Why?
|
| Benzamides | 1 | 2017 | 1832 | 0.030 |
Why?
|
| Methionine | 1 | 1992 | 159 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 995 | 0.020 |
Why?
|
| src-Family Kinases | 2 | 2005 | 478 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 2508 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 162 | 0.020 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 2216 | 0.020 |
Why?
|
| Lysosomes | 1 | 1993 | 347 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 7591 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2010 | 65 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 4757 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1995 | 803 | 0.020 |
Why?
|
| Exons | 1 | 1994 | 1328 | 0.020 |
Why?
|
| Piperazines | 1 | 2019 | 2101 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 309 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2010 | 682 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2005 | 4638 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 155 | 0.020 |
Why?
|
| Cell Migration Inhibition | 1 | 2008 | 16 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2009 | 93 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 9244 | 0.020 |
Why?
|
| Inducible T-Cell Co-Stimulator Ligand | 1 | 2008 | 20 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2003 | 394 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2007 | 29 | 0.020 |
Why?
|
| RNA | 1 | 2013 | 1013 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 114 | 0.020 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2006 | 7 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 9180 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 475 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1021 | 0.020 |
Why?
|
| Indoles | 1 | 2012 | 1009 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2007 | 104 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 252 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 292 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 2008 | 119 | 0.020 |
Why?
|
| Myeloproliferative Disorders | 1 | 1993 | 767 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 2278 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 2693 | 0.020 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2005 | 1 | 0.020 |
Why?
|
| Autoradiography | 1 | 2005 | 132 | 0.020 |
Why?
|
| Cobalt | 1 | 2005 | 55 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2007 | 844 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2004 | 249 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 3821 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 663 | 0.010 |
Why?
|
| Golgi Apparatus | 2 | 1996 | 147 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 521 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2003 | 18 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2009 | 1152 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2012 | 1823 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 376 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2004 | 257 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 1439 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 778 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12221 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 769 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2007 | 731 | 0.010 |
Why?
|
| Hypoxia | 1 | 2005 | 443 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 3552 | 0.010 |
Why?
|
| Membrane Glycoproteins | 2 | 1997 | 1073 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 2437 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2001 | 329 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 13658 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 1620 | 0.010 |
Why?
|
| Cell Movement | 1 | 2007 | 2466 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 31252 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 837 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 1547 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 32848 | 0.010 |
Why?
|
| Spleen Focus-Forming Viruses | 1 | 1997 | 2 | 0.010 |
Why?
|
| Aged | 1 | 2023 | 70117 | 0.010 |
Why?
|
| Biotin | 1 | 1997 | 69 | 0.010 |
Why?
|
| Surface Properties | 1 | 1997 | 180 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1997 | 629 | 0.010 |
Why?
|
| Thrombospondins | 1 | 1996 | 21 | 0.010 |
Why?
|
| Middle Aged | 1 | 2023 | 86204 | 0.010 |
Why?
|
| Kidney | 2 | 1995 | 2146 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 14289 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1995 | 33 | 0.010 |
Why?
|
| Hemagglutinins, Viral | 1 | 1995 | 45 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1995 | 45 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1995 | 73 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 568 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2005 | 5112 | 0.010 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1993 | 1 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1993 | 16 | 0.010 |
Why?
|
| Hexosaminidases | 1 | 1993 | 8 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1993 | 97 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 12926 | 0.010 |
Why?
|
| Chloroquine | 1 | 1993 | 53 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1993 | 355 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1992 | 121 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1992 | 114 | 0.010 |
Why?
|
| Biological Transport | 1 | 1992 | 597 | 0.010 |
Why?
|
| Oncogenes | 1 | 1992 | 673 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 5767 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1993 | 1271 | 0.000 |
Why?
|